Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 1, 2011
Are phylogenetic position, virulence, drug susceptibility and in vivo response to treatment in mycobacteria interrelated?Jakko van Ingen, Martin J Boeree, Dick van Soolingen, et al.Antimicrobial Agents and Chemotherapy|October 3, 2012
In vitro synergy between clofazimine and amikacin in treatment of nontuberculous mycobacterial diseaseJakko van Ingen, Sarah E Totten, Niels K Helstrom, et al.Antimicrobial Agents and Chemotherapy|July 14, 1998
Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosisD L Williams, L Spring, L Collins, et al.Tuberculosis (Edinburgh, Scotland)|August 5, 2008
Inhibition of M. tuberculosis in vitro in monocytes and in mice by aminomethylene pyrazinamide analogsWoo Jin Chung, Andrei Kornilov, Benjamin H Brodsky, et al.Journal of Clinical Microbiology|September 1, 1993
Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolatesS H Siddiqi, L B Heifets, M H Cynamon, et al.Annals of Internal Medicine|December 15, 1994
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study TeamR E Chaisson, C A Benson, M P Dube, et al.American Journal of Respiratory and Critical Care Medicine|October 6, 1997
Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study GroupR Hafner, J A Cohn, D J Wright, et al.American Journal of Respiratory and Critical Care Medicine|June 30, 2012
The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatmentJakko van Ingen, Eric F Egelund, Adrah Levin, et al.AIDS (London, England)|October 28, 1997
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinical Trials Group 222 Protocol TeamD C Perlman, W M El Sadr, L B Heifets, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 1998
Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trialE C Oldfield, W J Fessel, M W Dunne, et al.Pageof 5